{"id":"W4360992337","doi":"10.1056/nejmoa2302312","title":"Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer","year":2023,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":701,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; NRG Oncology; Merck","keywords":"Medicine; Pembrolizumab; Hazard ratio; Internal medicine; Carboplatin; Endometrial cancer; Cohort; Oncology; Placebo; Chemotherapy; Cancer; Surgery; Confidence interval; Pathology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001454483,0.0003159877,0.001130414,0.0003117055,0.0001916709,0.0002969455,0.0002796113,0.0004236571,0.001361302],"category_scores_gemma":[0.001492635,0.0002248722,0.000581285,0.0002957605,0.0003390307,0.0002563904,0.0002576384,0.00100085,0.0001604393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003199656,"about_ca_system_score_gemma":0.0005439781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004068899,"about_ca_topic_score_gemma":0.0009113381,"domain_scores_codex":[0.9995346,0.0003096645,0.00003438172,0.00004511927,0.00004460527,0.00003158617],"domain_scores_gemma":[0.9993631,0.00026616,0.0001779956,0.00003361118,0.00002060778,0.0001384891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7293318,0.007777453,0.007607569,0.002653329,0.001744905,0.000150248,0.000137514,0.002079291,0.01463382,0.0003710824,0.0008665238,0.2326464],"study_design_scores_gemma":[0.5923925,0.3652551,0.02839328,0.0003862565,0.001538096,0.000437621,0.00004384596,0.002108473,0.003215433,0.0005242098,0.005684278,0.00002099099],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723514,0.02502099,0.000433614,0.0003743701,0.0001591091,0.0006343586,0.00008704263,0.00002228975,0.0009167427],"genre_scores_gemma":[0.9907449,0.00695016,0.001060576,0.0002561248,0.0001559653,0.0004198407,0.0000805794,0.000002837585,0.0003289636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001454483,"threshold_uncertainty_score":0.007692158,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03607525677077003,"score_gpt":0.3494107491935854,"score_spread":0.3133354924228153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}